Literature DB >> 12133318

[The effect of dipyridamole and adenosine on pulmonary fibrosis in mice].

Jiahua Pan1, Wanling Lou, Lanju Chen, Xin Liu.   

Abstract

OBJECTIVE: To evaluate the effect of dipyridamole (DPM) and adenosine (ADO) on interstitial pulmonary fibrosis in mice.
METHODS: 100 mice injected with Bleomycin (BLM, 8.5 mg/kg) by intratracheal were divided into a control group and groups treated by DPM, ADO, DPM and theophyline (TH). Pulmonary pathology from day 4 to day 30 observations was studied by light and electron microscope.
RESULTS: Alveolar epithelial cell necrosis, lung tissue lesions by hypoxia and interstitial fibrosis were found in the BLM group after day 10. The necrotic epithelial cell, fibroblast proliferation, and the hypoxia induced tissue damage were less prominent, and the number and phagocytic function of macrophages were increased in the DPM and ADO treated groups. In the TH treated group, necrotic epithelial cells increased, the lung tissue was ischemic, and the differentiation of monocytes in pulmonary interstitial was slower.
CONCLUSION: DPM and ADO can inhibit fibroblast proliferation by improving microcirculation and promoting macrophage development and alveolar space reconstruction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133318

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  1 in total

1.  Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.